Olifant Medical, Inc.
San Antonio, TX · Medtech · Private
Enhanced nasopharyngeal airway (NPA) device for battlefield and emergency airway management
olifantmedical.com →- Grants
- $2.4M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $1.4M
- 3 awards · Defense
- #272 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Defense · Small Business Innovation Research (SBIR) Phase I - The Bougie Integrated Stylet: Improving First Pass Tracheal Intubation Success Through A Novel, Problem-focused Stylet Technology | $49,283 | |
| Federal grant | Department of Defense · Phase I · The Bougie Integrated Stylet: Improving First Pass Tracheal Intubation Success Through a Novel, Problem-Focused Stylet Technology | $50,000 | |
| Federal grant | Department of Defense · Phase II · A Multipurpose Droplet and Aerosol Mitigating Enclosure to Protect Health Care Professionals from Infectious Diseases | $994,056 | |
| Federal grant | Department of Defense · Phase I · Revisiting the Nasopharyngeal Airway (NPA): The Next-Level NPA | $249,465 | |
| Federal contract | Department of Defense · Dha SBIR Ph I Proposal H213-004-0100 Topic Dha 213-004 Title- Bougie-integrated Endotracheal Intubation Stylet -olifant Medical | $249,710 | |
| Federal grant | Department of Defense · Phase II · Revisiting the Nasopharyngeal Airway (NPA): The Next-Level NPA | $1,093,652 | |
| Federal contract | Department of Defense · Dha SBIR Phase II - Topic DHA213-004 Proposal H2-0724, Contractor Olifant Medical Inc., Titled Bougie Integrated Endotracheal Intubation Stylet, Medical R & D, Egs Log 2200472 | $1,099,278 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 269 | Coapt LLC | $1.4M | — |
| 270 | Biotex, Inc. | $1.4M | — |
| 271 | ADVANCED SILICON GROUP, INC. | $1.4M | $1.0M |
| 272 | Olifant Medical, Inc. | $1.4M | — |
| 273 | TISSUE TESTING TECHNOLOGIES LLC | $1.4M | — |
| 274 | AutoGenomics, Inc. | $1.4M | $71M |
| 275 | YOU TUNE HEARING PROTECTION LLC | $1.4M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.